Association between genetic polymorphism of angiotensin-converting enzyme gene and Parkinson's disease

Journal of the Neurological Sciences

Volumn 199, Issue 1-2, 2002, Pages 25-29

  Lin, Juei Jueng ^a,b   Yueh, Kuo Chu ^a   Chang, Dar Cheng ^a   Lin, Shinn Zong ^c  

^a Chu Shang Show Chwan Hospital   (Taiwan)

^b Chung Shan Hospital   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Angiotensin converting enzyme; Genetic polymorphism; Genetic susceptibility; Parkinson's disease

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENE NUMBER; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SENESCENCE;

AGE DISTRIBUTION; AGE FACTORS; ALLELES; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; RURAL POPULATION; TAIWAN; URBAN POPULATION;

EID: 0037099766     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(02)00081-3     Document Type: Article

References (30)

1. Parkinson's disease
2. Mutation in the α-synuclein gene identified in families with Parkinson's disease
3. Genetic aspects of Parkinson's disease
4. Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: Evidence for variable homozygous deletions in the Parkin gene in affected individuals
5. The roles of inheritance in sporadic Parkinson's disease: Evidence of a longitudinal study of dopaminergic function in twins
6. Parkinson's disease in twins: An etiology study
7. Angiotensin-converting enzyme: New concepts concerning its biological role
8. A rat brain isoenzyme of angiotensin-converting enzyme
9. Angiotensin I converting enzyme and its role in neuropeptide metabolism
10. The inflammatory response system of the brain: Implications for therapy of Alzheimer and other neurodegenerative diseases
11. Substance P and Parkinson's disease: A causal relationship?
12. Angiotensin converting enzyme modulates dopamine turnover in the striatum
13. The angiotensin converting enzyme (ACE) inhibitor, perindopril modifies the clinical features of Parkinson's disease
14. PCR detection of the insertion/deletion polymorphism of the human angiotensin I converting enzyme gene (DCPI)
15. Parkinson's Disease Society Brain Bank, London: Overview and research
16. Lack of association between deletion polymorphism of the ACE gene and ischemic vascular diseases in a Chinese population in Taiwan
17. Mistyping ACE heterozygotes
18. Lack of association between angiotensin-converting enzyme gene polymorphism and coronary heart disease in a Chinese population
19. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients with hypertension, non-insulin-dependent diabetes mellitus, and coronary heart disease in Taiwan
20. Angiotensin I converting enzyme gene polymorphism in Chinese patients with hypertension
21. Angiotensinogen and angiotensin-I converting enzyme gene polymorphism and the risk of coronary artery disease in Chinese
22. The ACE deletion polymorphism is not associated with Parkinson's disease
23. Meta-analysis of the ACE gene in ischemic stroke
24. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction
25. Deletion polymorphism of the angiotensin converting enzyme gene is associated with serum ACE concentration and increase risk for CAD in Japanese
26. Angiotensin-converting enzyme gene deletion polymorphism: A new risk factor for lacunar stroke, but not carotid atheroma
27. Polymorphism of the angiotensin-converting enzyme (ACE) gene in patients with thrombotic brain infarction
28. Oxidative damage in neurodegenerative disease
29. Survival and cause of death in a cohort of patients with parkinsonism: Possible clues to etiology?
30. Associations of disease with genetic markers: Déjà vu all over again